Long-term serologic follow-up of hepatitis C virus-seropositive homosexual men

O K Ndimbie1, S Nedjar, L Kingsley

  • 1Department of Pathology, University of Pittsburgh Medical Center, Pennsylvania.

Insights

Hepatitis C virus (HCV) infection can be challenging to diagnose due to variable seropositivity. Some individuals clear HCV infection, highlighting the need for improved diagnostic methods for this persistent public health concern.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection poses diagnostic challenges due to serologic test limitations.
  • Undiagnosed HCV can lead to ongoing community and transfusion-associated infections.

Purpose of the Study:

  • To longitudinally study individuals with Hepatitis C virus (HCV) seropositivity or at risk for seroconversion.
  • To characterize the course of HCV infection, including seroconversion and clearance, in a cohort of homosexual men.

Main Methods:

  • Analysis of sequential serum samples from 617 homosexual men in the Multicenter AIDS Cohort Study (1984-1992).
  • Testing included anti-HCV enzyme immunoassay (EIA), alanine aminotransferase, recombinant immunoblot (RIBA II), and nested PCR.
  • Longitudinal samples were analyzed to identify patterns of HCV seropositivity: persistent, intermittent, and rare.

Main Results:

  • 17 of 617 men (2.8%) were HCV seropositive at baseline; 9 of 600 seronegative men converted during follow-up.
  • HCV seropositivity patterns included persistent, intermittent, and rare; 35% showed intermittent or rare positivity over extended periods.
  • Four men seroconverted from positive to negative, indicating potential HCV clearance.
  • Nested PCR detected HCV in 76% of EIA-positive and 84% of RIBA-positive samples.

Conclusions:

  • A significant number of homosexual men were HCV seropositive with variable positivity over time.
  • Some individuals with Hepatitis C virus infection may become seronegative, posing diagnostic difficulties.
  • Intermittent or rare seropositivity presents a diagnostic challenge, necessitating refined testing strategies.